NIH funding increase stalled

A spending bill that would increase the National Institutes of Health 2009 budget by $1.2 billion over President Bush's linkurl:proposed NIH budget;http://www.the-scientist.com/blog/display/54277/ was sidelined by partisan wrangling in the full House Committee on Appropriations today (June 26). "[Bush's] budget would result in 6,000 medical research scientists who will no longer be able to get their research funded," said Representative linkurl:David Obey;http://www.the-scientist.com/article/di

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
A spending bill that would increase the National Institutes of Health 2009 budget by $1.2 billion over President Bush's linkurl:proposed NIH budget;http://www.the-scientist.com/blog/display/54277/ was sidelined by partisan wrangling in the full House Committee on Appropriations today (June 26). "[Bush's] budget would result in 6,000 medical research scientists who will no longer be able to get their research funded," said Representative linkurl:David Obey;http://www.the-scientist.com/article/display/7522/ (D-WI), who is the chair of the Appropriations Committee, in his opening remarks. "I don't believe members of this committee on either side of the aisle want to see this happen." The NIH budget increase is part of a larger Labor, Health and Education bill which would restore several cuts or boost slight increases to federal education, healthcare, and energy assistance programs. The bill would increase spending by $8.2 billion over last year's bill and by $8 billion over Bush's Labor, Health and Education budget request for FY 2009. The snafu in committee occurred when ranking member linkurl:Jerry Lewis;http://www.house.gov/jerrylewis/index.html (R-CA) proposed tabling the Labor, Health, and Education appropriations bill and instead considering the Interior appropriations bill, which addresses the issue of skyrocketing energy prices by "offering relief at the pump." In urging the committee to defeat the amendment, Obey said, "It's stunts like this that make people hate Washington." The bill must go through a final markup in the Appropriations Committee before heading to the House floor for a vote. The committee adjourned after Lewis proposed the amendment and has not yet scheduled a time to reconsider the bill. "Mr. Obey does not put up with nonsense," an Appropriations Committee spokesperson said, when asked why the session had been adjourned. A bill that would increase the FDA budget by $2.1 billion in the coming fiscal year faired better earlier this week when it was linkurl:passed;http://www.healthimaging.com/content/view/11286/118/ by the House Agriculture Subcommittee.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo